Tarsus Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
48.71
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.97
|
-0.84
|
0.13
|
13.40%
|
|
2022-06-30
|
-0.59
|
-0.24
|
0.35
|
59.32%
|
|
2022-03-31
|
-0.92
|
-0.98
|
-0.06
|
-6.52%
|
|
2021-12-31
|
-0.73
|
-0.72
|
0.01
|
1.37%
|
|
2021-09-30
|
-0.43
|
-0.76
|
-0.33
|
-76.74%
|
|
2021-06-30
|
-0.48
|
0.29
|
0.77
|
160.42%
|
|
2021-03-31
|
-0.64
|
0.47
|
1.11
|
173.44%
|
|
2020-12-31
|
-0.66
|
-0.68
|
-0.02
|
-3.03%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.06
|
|
2021-12-31
|
-0.72
|
|
2020-12-31
|
-4.58
|